Sign In
Buy PGNY
$31.13
-0.360 (-1.14%)
At Close: Jul 31, 2026
Progyny, Inc. Announces Participation at the Piper Sandler Healthcare Conference
12:00pm, Monday, 16'th Nov 2020
NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, t
Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript
03:05am, Sunday, 08'th Nov 2020
Progyny, Inc. (PGNY) CEO David Schlanger on Q3 2020 Results - Earnings Call Transcript
Progyny Grows Business But Stock May Be Priced For Perfection
05:37pm, Friday, 06'th Nov 2020
Progyny went public in October 2019, raising $130 million. The firm provides fertility and family planning benefit services in the United States.
Progyny (PGNY) Q3 Earnings Meet Estimates
07:40pm, Thursday, 05'th Nov 2020
Progyny (PGNY) delivered earnings and revenue surprises of 0.00% and 6.18%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Progyny: Q3 Earnings Insights
04:32pm, Thursday, 05'th Nov 2020
Shares of Progyny (NASDAQ:PGNY) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 66.67% over the past year to $0.05, which were in
